Searchable abstracts of presentations at key conferences in endocrinology

ea0011p641 | Neuroendocrinology and behaviour | ECE2006

Endocrine abnormalities are common in transsexual individuals

Iqbal SJ , Baig H , Green R , Barrett J , Seal LJ

Background: The most significant hypotheses regarding biological causes of transsexualism are based on the role of environmental hormonal exposure on neural development.Aim: This study was to analyse the baseline hormonal results in a population of transsexuals attending a single clinic to identify any abnormalities in hormone levels in these individuals.Method: A retrospective cohort study was carried out using data collected from...

ea0011p643 | Neuroendocrinology and behaviour | ECE2006

Complications of hormonal therapy in male to female transsexuals is uncommon

Baig H , Iqbal SJ , Green R , Barrett J , Seal LJ

Background: Transsexuals in Britain are prescribed hormones as part of Gender Reassignment Treatment. Oestrogen therapy is associated with the development of deep vein thrombosis (DVT) with a 25 fold increased risk, and breast cancer; particularly in the older age group and smokers.Aims: To investigate the risk of developing deep vein thromboses in male to female transsexual patients who are, or have been, on oestrogen therapy, and seeing if this differs...

ea0026p631 | Clinical case reports | ECE2011

‘Uterine neuroendocrine tumour: an unusual cause of hyponatraemia’ and the role of tolvaptan, a vasopressin V2 receptor antagonist

Mlawa G , Price S , Fraser L , Green R , Turner B , Guy R

Background: Hyponatraemia is the commonest electrolyte abnormality in clinical practice, and may be a biochemical manifestation of different diseases including malignancy. About 14% of hyponatremia in medical inpatients is due to underlying tumour related conditions.We present a case of 68 years widow who was referred by her General Practioner with 3 weeks history of nausea, occasional vomiting, confusion, increased urinary frequency, and urinary inconti...

ea0005p150 | Endocrine Tumours and Neoplasia | BES2003

Expression of vascular endothelial growth factor and its receptors in human anterior pituitary adenomas

Adams I , Henderson R , Green V , Foy P , Macfarlane I , Atkin S

Vascular Endothelial Growth Factor (VEGF) is an important growth factor, simulating the process of angiogenesis which is required for tumour progression. It mainly acts through 2 receptors VEGF-R1 and VEGF-R2. Whilst the presence of VEGF has been shown in pituitary adenomas, no study has undertaken the quantification of the expression of VEGF121, VEGF165, VEGF-R1 and VEGF-R2, and whether their expression may correlate.METHODS. We have used the technique of quantitative RT-...